regard, the company would like to report operating results for the second quarter of 2020 as follows Consolidated Financial Statements Ekachai Medical Care Public Company Limited and its subsidiaries
Ref U. SET 017/2017 7 August 2017 Subject: Summary of Operating Performance and Financial Status for Quarter 2/2017 To: President The Stock Exchange of Thailand U City Public Company Limited and its
049-E 1/2 RC 049/17 10 November 2017 Subj. : Report on the Company’s operating results for the third quarter of the year 2017 To : President of the Stock Exchange of Thailand The Board of Directors
Microsoft Word - GSC MD&A 2020_Q2 - Eng 07.08.2020 -Translation- ELCIDGSC016/2020 Date : 7 August 2020 Subject : Clarification on the changes of six months period end 30 June 2020 Operating results
Microsoft Word - ผลฆารà¸flำ๕ฎิฎà¸⁄าฎ_Q2_2562_ENG.doc (Translated) August 15, 2019 Ref FSS 132/2019 Subject: The Explanation of operating results of the six-month period ended
Limited ( the “ Company” ) and subsidiaries hereby submit the Annual Financial Statements, the three months period ending 31 March 2020 and 2019, together with the clarification of the performance of the
ADMS 30/07 1/2 RC 03/20 4 February 2020 Subject : Report on the Company’s operating results for the year 2019 Attention : President of the Stock Exchange of Thailand Jasmine International Public
19 เมษายน 2539 1 (TRANSLATION) Tor. For. 6 / 2020 May 14, 2020 Subject: (1) Submission of the Financial Statements for Q1/2020 (2) The resolution to appoint the Company’s auditor (3) Management
operation”) The Company would like to announce the operating results for the year ended December 31, 2019, which have been audited by the auditor as follows: For the years ended December 31, Continuing
: Overall operating results for the six-month period ended June 30, 2019 and June 30, 2018 (Unit: Thousand Baht) Consolidated Financial Statements Separate Financial Statements Increase (Decrease) Q2/2019 Q2